Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Lung Cancer

Free Subscription 18.06.2018 1 Ann Oncol 2 Ann Thorac Surg 5 Anticancer Res 1 Arch Pathol Lab Med 1 BMC Cancer 2 Cancer Sci 2 Chest 1 Clin Cancer Res 4 Clin Lung Cancer 1 Eur J Cancer 1 Hum Pathol 3 Int J Oncol 2 Int J Radiat Oncol Biol Phys 2 J Cancer Res Clin Oncol 7 J Thorac Oncol 1 Mol Cancer Ther 2 N Engl J Med 2 Nat Med 4 Oncol Rep

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Oncol

1. PINATO DJ, Kythreotou A, Mauri FA, Suardi E, et al
   Functional immune characterization of HIV-associated non-small cell lung cancer.
   Ann Oncol. 2018 Apr 20. pii: 4979448. doi: 10.1093.
   PubMed     Text format    
   
   

   
   Ann Thorac Surg

2. TANAKA F, Yokomise H, Soejima T, Uramoto H, et al
   Induction Chemo-radiation (50Gy) Followed by Surgery for Stage IIIA-N2 Non-small Cell Lung Cancer.
   Ann Thorac Surg. 2018 Jun 8. pii: S0003-4975(18)30823.
   PubMed     Text format     Abstract available
   
   
3. KRANTZ SB, Howington JA, Wood DE, Kim KW, et al
   Invasive Mediastinal Staging for Lung Cancer by Society of Thoracic Surgeons Database Participants.
   Ann Thorac Surg. 2018 Jun 5. pii: S0003-4975(18)30742.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

4. LAI JZ, Lai HH, Cao D
   Renal Cell Carcinoma, Unclassified with Medullary Phenotype and Synchronous Renal Clear Cell Carcinoma Present in a Patient with No Sickle Cell Trait/Disease: Diagnostic and Therapeutic Challenges.
   Anticancer Res. 2018;38:3757-3761.
   PubMed     Text format     Abstract available
   
   
5. HAGI T, Nakamura T, Sugino Y, Matsubara T, et al
   Is FDG-PET/CT Useful for Diagnosing Pulmonary Metastasis in Patients with Soft Tissue Sarcoma?
   Anticancer Res. 2018;38:3635-3639.
   PubMed     Text format     Abstract available
   
   
6. MASUHIRO K, Shiroyama T, Suzuki H, Takata SO, et al
   Impact of Pleural Effusion on Outcomes of Patients Receiving Osimertinib for NSCLC Harboring EGFR T790M.
   Anticancer Res. 2018;38:3567-3571.
   PubMed     Text format     Abstract available
   
   
7. KOMIYA K, Nakashima C, Nakamura T, Hirakawa H, et al
   Current Status and Problems of T790M Detection, a Molecular Biomarker of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors, with Liquid Biopsy and Re-biopsy.
   Anticancer Res. 2018;38:3559-3566.
   PubMed     Text format     Abstract available
   
   
8. LIN MX, Lin SH, Lin CC, Yang CC, et al
   In Vitro and In Vivo Antitumor Effects of Pyrimethamine on Non-small Cell Lung Cancers.
   Anticancer Res. 2018;38:3435-3445.
   PubMed     Text format     Abstract available
   
   

   
   Arch Pathol Lab Med

9. LUK PP, Selinger CI, Mahar A, Cooper WA, et al
   Biomarkers for ALK and ROS1 in Lung Cancer: Immunohistochemistry and Fluorescent In Situ Hybridization.
   Arch Pathol Lab Med. 2018 Jun 14. doi: 10.5858/arpa.2017-0502.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

10. HOU X, Gong R, Zhan J, Zhou T, et al
    p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells.
    BMC Cancer. 2018;18:641.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Sci

11. WATANABE M, Kenmotsu H, Ko R, Wakuda K, et al
    Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter.
    Cancer Sci. 2018 Jun 14. doi: 10.1111/cas.13692.
    PubMed     Text format     Abstract available
    
    
12. QIN T, Huang D, Liu Z, Zhang X, et al
    TNFSF15 promotes lymphatic metastasis via up-regulation of VEGFC in a mouse model of lung cancer.
    Cancer Sci. 2018 Jun 11. doi: 10.1111/cas.13665.
    PubMed     Text format     Abstract available
    
    

    
    Chest

13. WOOD DE
    POINT: Should Lung Cancer Screening Be Expanded to Persons Who Don't Currently Meet Accepted Criteria Set Forth by the CHEST Guidelines on Lung Cancer Screening? Yes.
    Chest. 2018;153:1299-1302.
    PubMed     Text format    
    
    
14. MAZZONE PJ
    COUNTERPOINT: Should Lung Cancer Screening Be Expanded to Persons Who Don't Currently Meet Accepted Criteria Set Forth by the CHEST Guidelines on Lung Cancer Screening? No.
    Chest. 2018;153:1303-1305.
    PubMed     Text format    
    
    

    
    Clin Cancer Res

15. SAIGI M, Alburquerque-Bejar JJ, McLEER-Florin A, Pereira C, et al
    MET-oncogenic and JAK2-inactivating alterations are independent factors that affect regulation of PD-L1 expression in lung cancer.
    Clin Cancer Res. 2018 Jun 13. pii: 1078-0432.CCR-18-0267.
    PubMed     Text format     Abstract available
    
    

    
    Clin Lung Cancer

16. ATAGI S, Mizusawa J, Ishikura S, Takahashi T, et al
    Chemoradiotherapy in Elderly Patients With Non-Small-Cell Lung Cancer: Long-Term Follow-Up of a Randomized Trial (JCOG0301).
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30100.
    PubMed     Text format     Abstract available
    
    
17. BITTONI MA, Arunachalam A, Li H, Camacho R, et al
    Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non-small-cell Lung Cancer: A Retrospective Study.
    Clin Lung Cancer. 2018 May 7. pii: S1525-7304(18)30099.
    PubMed     Text format     Abstract available
    
    
18. SAIKI M, Kitazono S, Yoshizawa T, Dotsu Y, et al
    Characterization of Computed Tomography Imaging of Rearranged During Transfection-rearranged Lung Cancer.
    Clin Lung Cancer. 2018 May 10. pii: S1525-7304(18)30088.
    PubMed     Text format     Abstract available
    
    
19. RODRIGUEZ DE DIOS N, Counago F, Lopez JL, Calvo P, et al
    Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radia
    Clin Lung Cancer. 2018 May 10. pii: S1525-7304(18)30108.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Cancer

20. LINDSAY CR, Jamal-Hanjani M, Forster M, Blackhall F, et al
    KRAS: Reasons for optimism in lung cancer.
    Eur J Cancer. 2018;99:20-27.
    PubMed     Text format     Abstract available
    
    

    
    Hum Pathol

21. RAKAEE M, Kilvaer TK, Dalen SM, Richardsen E, et al
    Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer.
    Hum Pathol. 2018 Jun 6. pii: S0046-8177(18)30185.
    PubMed     Text format     Abstract available
    
    

    
    Int J Oncol

22. ANISIEWICZ A, Pawlik A, Filip-Psurska B, Turlej E, et al
    Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer.
    Int J Oncol. 2018;52:103-126.
    PubMed     Text format     Abstract available
    
    
23. FUJIWARA-KURODA A, Kato T, Abiko T, Tsuchikawa T, et al
    Prognostic value of MAGEA4 in primary lung cancer depends on subcellular localization and p53 status.
    Int J Oncol. 2018 May 31. doi: 10.3892/ijo.2018.4425.
    PubMed     Text format     Abstract available
    
    
24. ZHAO YY, Wu Q, Wu ZB, Zhang JJ, et al
    Microwave hyperthermia promotes caspase3-dependent apoptosis and induces G2/M checkpoint arrest via the ATM pathway in nonsmall cell lung cancer cells.
    Int J Oncol. 2018 Jun 13. doi: 10.3892/ijo.2018.4439.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

25. TOPKAN E, Selek U, Ozdemir Y, Yildirim BA, et al
    Incidence and Impact of Pretreatment Tumor Cavitation on Survival Outcomes of Stage III Squamous Cell Lung Cancer Patients Treated With Radical Concurrent Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018 Apr 26. pii: S0360-3016(18)30720.
    PubMed     Text format     Abstract available
    
    
26. YAMAMOTO T, Kabus S, Bal M, Bzdusek K, et al
    Changes in Regional Ventilation During Treatment and Dosimetric Advantages of CT Ventilation Image Guided Radiation Therapy for Locally Advanced Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2018 May 4. pii: S0360-3016(18)30741.
    PubMed     Text format     Abstract available
    
    

    
    J Cancer Res Clin Oncol

27. WANG Y, Zheng D, Zheng J, Huang Q, et al
    Predictors of recurrence and survival of pathological T1N0M0 invasive adenocarcinoma following lobectomy.
    J Cancer Res Clin Oncol. 2018;144:1015-1023.
    PubMed     Text format     Abstract available
    
    
28. LI C, Liu H, Zhang B, Gong L, et al
    Whole-exome sequencing identifies key mutated genes in T790M wildtype/cMET-unamplified lung adenocarcinoma with acquired resistance to first-generation EGFR tyrosine kinase inhibitors.
    J Cancer Res Clin Oncol. 2018;144:1079-1086.
    PubMed     Text format     Abstract available
    
    

    
    J Thorac Oncol

29. WANG S, Yang L, Ci B, Maclean M, et al
    Development and Validation of a Nomogram Prognostic Model for Small-Cell Lung Cancer Patients.
    J Thorac Oncol. 2018 Jun 11. pii: S1556-0864(18)30687.
    PubMed     Text format     Abstract available
    
    
30. HARATAKE N, Tagawa T, Hirai F, Toyokawa G, et al
    Stevens-Johnson syndrome induced by pembrolizumab in a lung cancer patient.
    J Thorac Oncol. 2018 Jun 6. pii: S1556-0864(18)30681.
    PubMed     Text format    
    
    
31. JONES CC, Mercaldo SF, Blume JD, Wenzlaff AS, et al
    Racial disparities in lung cancer survival: The contribution of stage, treatment, and ancestry.
    J Thorac Oncol. 2018 Jun 6. pii: S1556-0864(18)30682.
    PubMed     Text format     Abstract available
    
    
32. PARK S, Ahn BC, Lim SW, Sun JM, et al
    Characteristics and outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practice.
    J Thorac Oncol. 2018 Jun 5. pii: S1556-0864(18)30673.
    PubMed     Text format     Abstract available
    
    
33. GERAUD A, Mezquita L, Bigot F, Caramella C, et al
    Long leptomeningeal responses with brigatinib in two heavily pre-treated ALK-rearranged non-small cell lung cancer patients.
    J Thorac Oncol. 2018 Jun 6. pii: S1556-0864(18)30683.
    PubMed     Text format    
    
    
34. YEGYA-RAMAN N, Wang K, Kim S, Reyhan M, et al
    Dosimetric Predictors of Symptomatic Cardiac Events after Conventional-Dose Chemoradiation Therapy for Inoperable Non-Small Cell Lung Cancer.
    J Thorac Oncol. 2018 Jun 5. pii: S1556-0864(18)30675.
    PubMed     Text format     Abstract available
    
    
35. ROLFO C, Mack PC, Scagliotti GV, Baas P, et al
    IASLC Statement Paper: Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC).
    J Thorac Oncol. 2018 Jun 6. pii: S1556-0864(18)30680.
    PubMed     Text format     Abstract available
    
    

    
    Mol Cancer Ther

36. NJATCHA C, Farooqui M, Kornberg A, Johnson DE, et al
    STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non-Small Cell Lung Cancer.
    Mol Cancer Ther. 2018 Jun 11. pii: 1535-7163.MCT-17-1194.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

37. SCLAFANI A, VanderLaan P
    Lymphangioleiomyomatosis.
    N Engl J Med. 2018;378:2224.
    PubMed     Text format    
    
    
38. DE KOCK L, Fahiminiya S, Fiset PO, Astigarraga I, et al
    Infantile Pulmonary Teratoid Tumor.
    N Engl J Med. 2018;378:2238-2240.
    PubMed     Text format    
    
    

    
    Nat Med

39. THOMMEN DS, Koelzer VH, Herzig P, Roller A, et al
    A transcriptionally and functionally distinct PD-1(+) CD8(+) T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade.
    Nat Med. 2018 Jun 11. pii: 10.1038/s41591-018-0057.
    PubMed     Text format     Abstract available
    
    
40. LISSANU DERIBE Y, Sun Y, Terranova C, Khan F, et al
    Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer.
    Nat Med. 2018 Jun 8. pii: 10.1038/s41591-018-0019.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

41. JIANG K, Shen M, Chen Y, Xu W, et al
    miR150 promotes the proliferation and migration of nonsmall cell lung cancer cells by regulating the SIRT2/JMJD2A signaling pathway.
    Oncol Rep. 2018 Jun 12. doi: 10.3892/or.2018.6487.
    PubMed     Text format     Abstract available
    
    
42. LI F, Zhu T, Yue Y, Zhu X, et al
    Preliminary mechanisms of regulating PDL1 expression in nonsmall cell lung cancer during the EMT process.
    Oncol Rep. 2018 Jun 5. doi: 10.3892/or.2018.6474.
    PubMed     Text format     Abstract available
    
    
43. JIN D, Wu Y, Shao C, Gao Y, et al
    Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human nonsmall lung cancer cells by regulating the YAP pathway.
    Oncol Rep. 2018 Jun 12. doi: 10.3892/or.2018.6486.
    PubMed     Text format     Abstract available
    
    
44. JI Y, Jiang J, Huang L, Feng W, et al
    Spermassociated antigen 4 (SPAG4) as a new cancer marker interacts with Nesprin3 to regulate cell migration in lung carcinoma.
    Oncol Rep. 2018 Jun 4. doi: 10.3892/or.2018.6473.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: